BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8472729)

  • 1. Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety.
    Schneider J; Centeno MM; Montoya F; Rodriguez-Escudero FJ
    Eur J Gynaecol Oncol; 1993; 14(1):36-9. PubMed ID: 8472729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor recurrence following negative second-look laparotomy in ovarian carcinoma].
    Schneider J; Barbazan M; Centeno M; Montoya F; Neyro JL; Rodriguez-Escudero FJ
    Zentralbl Gynakol; 1991; 113(22):1246-50. PubMed ID: 1755261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
    McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
    Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant chemotherapy of cancer of the ovary].
    Cappelaere P; Horner-Vallet D; Demaille A
    Bull Cancer; 1984; 71(4):363-9. PubMed ID: 6498348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-look surgery (SLO) in the management of carcinoma of the ovary.
    Hernádi Z; Sápy T; Lukácskó L; Borsos A
    Acta Chir Hung; 1997; 36(1-4):128-9. PubMed ID: 9408314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
    Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
    Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does negative clinical evaluation of ovarian carcinoma after full course of chemotherapy correlate with second-look laparotomy findings?
    Zorlu CG; Cobanoglu O; Caglar T; Ergun Y; Kuscu E; Alaybeyoglu T
    J Surg Oncol; 1994 Apr; 55(4):255-8. PubMed ID: 8159008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
    Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
    Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
    Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-look laparotomy in the management of patients after radical surgery for ovarian cancer.
    Tuxen MK; Lund B; Hansen OP; Hansen M
    Ann Oncol; 1993 Feb; 4(2):169-71. PubMed ID: 8448085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-look laparotomy; factors affecting the results and the prognosis.
    Ozalp S; Yalcin OT; Dundar E; Hassa H; Yildirim A; Okur A
    Eur J Gynaecol Oncol; 1999; 20(5-6):398-402. PubMed ID: 10609505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of second-look laparotomy for patients with epithelial ovarian carcinoma.
    Kamura T; Tsukamoto N; Saito T; Kaku T; Matsuyama T; Nakano H
    Int J Gynaecol Obstet; 1990 Oct; 33(2):141-7. PubMed ID: 1976547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
    Atad J; Bornstein J; Steiner M; Weill S; Lurie M; Abramovici H
    Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-look operations in ovarian cancer.
    Schwartz PE; Smith JP
    Am J Obstet Gynecol; 1980 Dec; 138(8):1124-30. PubMed ID: 7446620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and outcomes of recurrent disease after a negative second look laparotomy.
    Ayhan A; Gultekin M; Dursun P; Dogan NU; Aksan G; Guven S; Yuce K
    J Surg Oncol; 2008 Mar; 97(3):226-30. PubMed ID: 18050284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.